カテゴリ： Market Monitor Global, 世界, 医療/バイオ

新型薬物再構成システムのグローバル市場展望 2023年-2029年：瓶詰め、袋詰め

■ 英語タイトル：Novel Drug Reconstitution System Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23JU5389）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23JU5389
■ 発行日：2023年6月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医療機器＆消耗品
■ ページ数：110
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[新型薬物再構成システムのグローバル市場展望 2023年-2029年：瓶詰め、袋詰め]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界の新型薬物再構成システム市場規模と予測を収録しています。・世界の新型薬物再構成システム市場：売上、2018年-2023年、2024年-2029年
・世界の新型薬物再構成システム市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の新型薬物再構成システム市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「瓶詰め」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

新型薬物再構成システムのグローバル主要企業は、3M Innovative Properties、 Baxter、 JW Group、 Pfizer、 Takeda、 Aerie Pharmaceuticals、 Ionis Pharmaceuticals、 Eisai、 Covis Pharma、 Allergan、 Gilead Sciences、 Bayer Healthcare、 Credence Medsystems、 Amgen、 Roche、 GlaxoSmithKline、 Vertex Pharmaceuticals、 Synergy Pharmaceuticals、 Otsuka Pharmaceuticalなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、新型薬物再構成システムのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の新型薬物再構成システム市場：タイプ別、2018年-2023年、2024年-2029年
世界の新型薬物再構成システム市場：タイプ別市場シェア、2022年
・瓶詰め、袋詰め

世界の新型薬物再構成システム市場：用途別、2018年-2023年、2024年-2029年
世界の新型薬物再構成システム市場：用途別市場シェア、2022年
・病院、診療所、その他

世界の新型薬物再構成システム市場：地域・国別、2018年-2023年、2024年-2029年
世界の新型薬物再構成システム市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における新型薬物再構成システムのグローバル売上、2018年-2023年
・主要企業における新型薬物再構成システムのグローバル売上シェア、2022年
・主要企業における新型薬物再構成システムのグローバル販売量、2018年-2023年
・主要企業における新型薬物再構成システムのグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
3M Innovative Properties、 Baxter、 JW Group、 Pfizer、 Takeda、 Aerie Pharmaceuticals、 Ionis Pharmaceuticals、 Eisai、 Covis Pharma、 Allergan、 Gilead Sciences、 Bayer Healthcare、 Credence Medsystems、 Amgen、 Roche、 GlaxoSmithKline、 Vertex Pharmaceuticals、 Synergy Pharmaceuticals、 Otsuka Pharmaceutical

*************************************************************

・調査・分析レポートの概要
新型薬物再構成システム市場の定義
市場セグメント
世界の新型薬物再構成システム市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の新型薬物再構成システム市場規模
世界の新型薬物再構成システム市場規模：2022年 VS 2029年
世界の新型薬物再構成システム市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの新型薬物再構成システムの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の新型薬物再構成システム製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：瓶詰め、袋詰め
新型薬物再構成システムのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、診療所、その他
新型薬物再構成システムの用途別グローバル売上・予測

・地域別市場分析
地域別新型薬物再構成システム市場規模 2022年と2029年
地域別新型薬物再構成システム売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
3M Innovative Properties、 Baxter、 JW Group、 Pfizer、 Takeda、 Aerie Pharmaceuticals、 Ionis Pharmaceuticals、 Eisai、 Covis Pharma、 Allergan、 Gilead Sciences、 Bayer Healthcare、 Credence Medsystems、 Amgen、 Roche、 GlaxoSmithKline、 Vertex Pharmaceuticals、 Synergy Pharmaceuticals、 Otsuka Pharmaceutical
...

This report aims to provide a comprehensive presentation of the global market for Novel Drug Reconstitution System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Novel Drug Reconstitution System. This report contains market size and forecasts of Novel Drug Reconstitution System in global, including the following market information:
Global Novel Drug Reconstitution System Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Novel Drug Reconstitution System Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Novel Drug Reconstitution System companies in 2022 (%)
The global Novel Drug Reconstitution System market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Bottled Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Novel Drug Reconstitution System include 3M Innovative Properties, Baxter, JW Group, Pfizer, Takeda, Aerie Pharmaceuticals, Ionis Pharmaceuticals, Eisai and Covis Pharma, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Novel Drug Reconstitution System manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Novel Drug Reconstitution System Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Novel Drug Reconstitution System Market Segment Percentages, by Type, 2022 (%)
Bottled
Bagged
Global Novel Drug Reconstitution System Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Novel Drug Reconstitution System Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Others
Global Novel Drug Reconstitution System Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Novel Drug Reconstitution System Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Novel Drug Reconstitution System revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Novel Drug Reconstitution System revenues share in global market, 2022 (%)
Key companies Novel Drug Reconstitution System sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Novel Drug Reconstitution System sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
3M Innovative Properties
Baxter
JW Group
Pfizer
Takeda
Aerie Pharmaceuticals
Ionis Pharmaceuticals
Eisai
Covis Pharma
Allergan
Gilead Sciences
Bayer Healthcare
Credence Medsystems
Amgen
Roche
GlaxoSmithKline
Vertex Pharmaceuticals
Synergy Pharmaceuticals
Otsuka Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Novel Drug Reconstitution System, market overview.
Chapter 2: Global Novel Drug Reconstitution System market size in revenue and volume.
Chapter 3: Detailed analysis of Novel Drug Reconstitution System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Novel Drug Reconstitution System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Novel Drug Reconstitution System capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Novel Drug Reconstitution System Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Novel Drug Reconstitution System Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Novel Drug Reconstitution System Overall Market Size
2.1 Global Novel Drug Reconstitution System Market Size: 2022 VS 2029
2.2 Global Novel Drug Reconstitution System Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Novel Drug Reconstitution System Sales: 2018-2029
3 Company Landscape
3.1 Top Novel Drug Reconstitution System Players in Global Market
3.2 Top Global Novel Drug Reconstitution System Companies Ranked by Revenue
3.3 Global Novel Drug Reconstitution System Revenue by Companies
3.4 Global Novel Drug Reconstitution System Sales by Companies
3.5 Global Novel Drug Reconstitution System Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Novel Drug Reconstitution System Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Novel Drug Reconstitution System Product Type
3.8 Tier 1, Tier 2 and Tier 3 Novel Drug Reconstitution System Players in Global Market
3.8.1 List of Global Tier 1 Novel Drug Reconstitution System Companies
3.8.2 List of Global Tier 2 and Tier 3 Novel Drug Reconstitution System Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Novel Drug Reconstitution System Market Size Markets, 2022 & 2029
4.1.2 Bottled
4.1.3 Bagged
4.2 By Type – Global Novel Drug Reconstitution System Revenue & Forecasts
4.2.1 By Type – Global Novel Drug Reconstitution System Revenue, 2018-2023
4.2.2 By Type – Global Novel Drug Reconstitution System Revenue, 2024-2029
4.2.3 By Type – Global Novel Drug Reconstitution System Revenue Market Share, 2018-2029
4.3 By Type – Global Novel Drug Reconstitution System Sales & Forecasts
4.3.1 By Type – Global Novel Drug Reconstitution System Sales, 2018-2023
4.3.2 By Type – Global Novel Drug Reconstitution System Sales, 2024-2029
4.3.3 By Type – Global Novel Drug Reconstitution System Sales Market Share, 2018-2029
4.4 By Type – Global Novel Drug Reconstitution System Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Novel Drug Reconstitution System Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application – Global Novel Drug Reconstitution System Revenue & Forecasts
5.2.1 By Application – Global Novel Drug Reconstitution System Revenue, 2018-2023
5.2.2 By Application – Global Novel Drug Reconstitution System Revenue, 2024-2029
5.2.3 By Application – Global Novel Drug Reconstitution System Revenue Market Share, 2018-2029
5.3 By Application – Global Novel Drug Reconstitution System Sales & Forecasts
5.3.1 By Application – Global Novel Drug Reconstitution System Sales, 2018-2023
5.3.2 By Application – Global Novel Drug Reconstitution System Sales, 2024-2029
5.3.3 By Application – Global Novel Drug Reconstitution System Sales Market Share, 2018-2029
5.4 By Application – Global Novel Drug Reconstitution System Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Novel Drug Reconstitution System Market Size, 2022 & 2029
6.2 By Region – Global Novel Drug Reconstitution System Revenue & Forecasts
6.2.1 By Region – Global Novel Drug Reconstitution System Revenue, 2018-2023
6.2.2 By Region – Global Novel Drug Reconstitution System Revenue, 2024-2029
6.2.3 By Region – Global Novel Drug Reconstitution System Revenue Market Share, 2018-2029
6.3 By Region – Global Novel Drug Reconstitution System Sales & Forecasts
6.3.1 By Region – Global Novel Drug Reconstitution System Sales, 2018-2023
6.3.2 By Region – Global Novel Drug Reconstitution System Sales, 2024-2029
6.3.3 By Region – Global Novel Drug Reconstitution System Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Novel Drug Reconstitution System Revenue, 2018-2029
6.4.2 By Country – North America Novel Drug Reconstitution System Sales, 2018-2029
6.4.3 US Novel Drug Reconstitution System Market Size, 2018-2029
6.4.4 Canada Novel Drug Reconstitution System Market Size, 2018-2029
6.4.5 Mexico Novel Drug Reconstitution System Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Novel Drug Reconstitution System Revenue, 2018-2029
6.5.2 By Country – Europe Novel Drug Reconstitution System Sales, 2018-2029
6.5.3 Germany Novel Drug Reconstitution System Market Size, 2018-2029
6.5.4 France Novel Drug Reconstitution System Market Size, 2018-2029
6.5.5 U.K. Novel Drug Reconstitution System Market Size, 2018-2029
6.5.6 Italy Novel Drug Reconstitution System Market Size, 2018-2029
6.5.7 Russia Novel Drug Reconstitution System Market Size, 2018-2029
6.5.8 Nordic Countries Novel Drug Reconstitution System Market Size, 2018-2029
6.5.9 Benelux Novel Drug Reconstitution System Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Novel Drug Reconstitution System Revenue, 2018-2029
6.6.2 By Region – Asia Novel Drug Reconstitution System Sales, 2018-2029
6.6.3 China Novel Drug Reconstitution System Market Size, 2018-2029
6.6.4 Japan Novel Drug Reconstitution System Market Size, 2018-2029
6.6.5 South Korea Novel Drug Reconstitution System Market Size, 2018-2029
6.6.6 Southeast Asia Novel Drug Reconstitution System Market Size, 2018-2029
6.6.7 India Novel Drug Reconstitution System Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Novel Drug Reconstitution System Revenue, 2018-2029
6.7.2 By Country – South America Novel Drug Reconstitution System Sales, 2018-2029
6.7.3 Brazil Novel Drug Reconstitution System Market Size, 2018-2029
6.7.4 Argentina Novel Drug Reconstitution System Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Novel Drug Reconstitution System Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Novel Drug Reconstitution System Sales, 2018-2029
6.8.3 Turkey Novel Drug Reconstitution System Market Size, 2018-2029
6.8.4 Israel Novel Drug Reconstitution System Market Size, 2018-2029
6.8.5 Saudi Arabia Novel Drug Reconstitution System Market Size, 2018-2029
6.8.6 UAE Novel Drug Reconstitution System Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 3M Innovative Properties
7.1.1 3M Innovative Properties Company Summary
7.1.2 3M Innovative Properties Business Overview
7.1.3 3M Innovative Properties Novel Drug Reconstitution System Major Product Offerings
7.1.4 3M Innovative Properties Novel Drug Reconstitution System Sales and Revenue in Global (2018-2023)
7.1.5 3M Innovative Properties Key News & Latest Developments
7.2 Baxter
7.2.1 Baxter Company Summary
7.2.2 Baxter Business Overview
7.2.3 Baxter Novel Drug Reconstitution System Major Product Offerings
7.2.4 Baxter Novel Drug Reconstitution System Sales and Revenue in Global (2018-2023)
7.2.5 Baxter Key News & Latest Developments
7.3 JW Group
7.3.1 JW Group Company Summary
7.3.2 JW Group Business Overview
7.3.3 JW Group Novel Drug Reconstitution System Major Product Offerings
7.3.4 JW Group Novel Drug Reconstitution System Sales and Revenue in Global (2018-2023)
7.3.5 JW Group Key News & Latest Developments
7.4 Pfizer
7.4.1 Pfizer Company Summary
7.4.2 Pfizer Business Overview
7.4.3 Pfizer Novel Drug Reconstitution System Major Product Offerings
7.4.4 Pfizer Novel Drug Reconstitution System Sales and Revenue in Global (2018-2023)
7.4.5 Pfizer Key News & Latest Developments
7.5 Takeda
7.5.1 Takeda Company Summary
7.5.2 Takeda Business Overview
7.5.3 Takeda Novel Drug Reconstitution System Major Product Offerings
7.5.4 Takeda Novel Drug Reconstitution System Sales and Revenue in Global (2018-2023)
7.5.5 Takeda Key News & Latest Developments
7.6 Aerie Pharmaceuticals
7.6.1 Aerie Pharmaceuticals Company Summary
7.6.2 Aerie Pharmaceuticals Business Overview
7.6.3 Aerie Pharmaceuticals Novel Drug Reconstitution System Major Product Offerings
7.6.4 Aerie Pharmaceuticals Novel Drug Reconstitution System Sales and Revenue in Global (2018-2023)
7.6.5 Aerie Pharmaceuticals Key News & Latest Developments
7.7 Ionis Pharmaceuticals
7.7.1 Ionis Pharmaceuticals Company Summary
7.7.2 Ionis Pharmaceuticals Business Overview
7.7.3 Ionis Pharmaceuticals Novel Drug Reconstitution System Major Product Offerings
7.7.4 Ionis Pharmaceuticals Novel Drug Reconstitution System Sales and Revenue in Global (2018-2023)
7.7.5 Ionis Pharmaceuticals Key News & Latest Developments
7.8 Eisai
7.8.1 Eisai Company Summary
7.8.2 Eisai Business Overview
7.8.3 Eisai Novel Drug Reconstitution System Major Product Offerings
7.8.4 Eisai Novel Drug Reconstitution System Sales and Revenue in Global (2018-2023)
7.8.5 Eisai Key News & Latest Developments
7.9 Covis Pharma
7.9.1 Covis Pharma Company Summary
7.9.2 Covis Pharma Business Overview
7.9.3 Covis Pharma Novel Drug Reconstitution System Major Product Offerings
7.9.4 Covis Pharma Novel Drug Reconstitution System Sales and Revenue in Global (2018-2023)
7.9.5 Covis Pharma Key News & Latest Developments
7.10 Allergan
7.10.1 Allergan Company Summary
7.10.2 Allergan Business Overview
7.10.3 Allergan Novel Drug Reconstitution System Major Product Offerings
7.10.4 Allergan Novel Drug Reconstitution System Sales and Revenue in Global (2018-2023)
7.10.5 Allergan Key News & Latest Developments
7.11 Gilead Sciences
7.11.1 Gilead Sciences Company Summary
7.11.2 Gilead Sciences Novel Drug Reconstitution System Business Overview
7.11.3 Gilead Sciences Novel Drug Reconstitution System Major Product Offerings
7.11.4 Gilead Sciences Novel Drug Reconstitution System Sales and Revenue in Global (2018-2023)
7.11.5 Gilead Sciences Key News & Latest Developments
7.12 Bayer Healthcare
7.12.1 Bayer Healthcare Company Summary
7.12.2 Bayer Healthcare Novel Drug Reconstitution System Business Overview
7.12.3 Bayer Healthcare Novel Drug Reconstitution System Major Product Offerings
7.12.4 Bayer Healthcare Novel Drug Reconstitution System Sales and Revenue in Global (2018-2023)
7.12.5 Bayer Healthcare Key News & Latest Developments
7.13 Credence Medsystems
7.13.1 Credence Medsystems Company Summary
7.13.2 Credence Medsystems Novel Drug Reconstitution System Business Overview
7.13.3 Credence Medsystems Novel Drug Reconstitution System Major Product Offerings
7.13.4 Credence Medsystems Novel Drug Reconstitution System Sales and Revenue in Global (2018-2023)
7.13.5 Credence Medsystems Key News & Latest Developments
7.14 Amgen
7.14.1 Amgen Company Summary
7.14.2 Amgen Business Overview
7.14.3 Amgen Novel Drug Reconstitution System Major Product Offerings
7.14.4 Amgen Novel Drug Reconstitution System Sales and Revenue in Global (2018-2023)
7.14.5 Amgen Key News & Latest Developments
7.15 Roche
7.15.1 Roche Company Summary
7.15.2 Roche Business Overview
7.15.3 Roche Novel Drug Reconstitution System Major Product Offerings
7.15.4 Roche Novel Drug Reconstitution System Sales and Revenue in Global (2018-2023)
7.15.5 Roche Key News & Latest Developments
7.16 GlaxoSmithKline
7.16.1 GlaxoSmithKline Company Summary
7.16.2 GlaxoSmithKline Business Overview
7.16.3 GlaxoSmithKline Novel Drug Reconstitution System Major Product Offerings
7.16.4 GlaxoSmithKline Novel Drug Reconstitution System Sales and Revenue in Global (2018-2023)
7.16.5 GlaxoSmithKline Key News & Latest Developments
7.17 Vertex Pharmaceuticals
7.17.1 Vertex Pharmaceuticals Company Summary
7.17.2 Vertex Pharmaceuticals Business Overview
7.17.3 Vertex Pharmaceuticals Novel Drug Reconstitution System Major Product Offerings
7.17.4 Vertex Pharmaceuticals Novel Drug Reconstitution System Sales and Revenue in Global (2018-2023)
7.17.5 Vertex Pharmaceuticals Key News & Latest Developments
7.18 Synergy Pharmaceuticals
7.18.1 Synergy Pharmaceuticals Company Summary
7.18.2 Synergy Pharmaceuticals Business Overview
7.18.3 Synergy Pharmaceuticals Novel Drug Reconstitution System Major Product Offerings
7.18.4 Synergy Pharmaceuticals Novel Drug Reconstitution System Sales and Revenue in Global (2018-2023)
7.18.5 Synergy Pharmaceuticals Key News & Latest Developments
7.19 Otsuka Pharmaceutical
7.19.1 Otsuka Pharmaceutical Company Summary
7.19.2 Otsuka Pharmaceutical Business Overview
7.19.3 Otsuka Pharmaceutical Novel Drug Reconstitution System Major Product Offerings
7.19.4 Otsuka Pharmaceutical Novel Drug Reconstitution System Sales and Revenue in Global (2018-2023)
7.19.5 Otsuka Pharmaceutical Key News & Latest Developments
8 Global Novel Drug Reconstitution System Production Capacity, Analysis
8.1 Global Novel Drug Reconstitution System Production Capacity, 2018-2029
8.2 Novel Drug Reconstitution System Production Capacity of Key Manufacturers in Global Market
8.3 Global Novel Drug Reconstitution System Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Novel Drug Reconstitution System Supply Chain Analysis
10.1 Novel Drug Reconstitution System Industry Value Chain
10.2 Novel Drug Reconstitution System Upstream Market
10.3 Novel Drug Reconstitution System Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Novel Drug Reconstitution System Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • アセタゾラミド薬のグローバル市場展望 2023年-2029年：錠剤、カプセル、注射剤
  • 脳神経外科用薬剤のグローバル市場展望 2023年-2029年：錠剤、液剤、カプセル剤、その他
  • 抗がん剤のグローバル市場展望 2023年-2029年：分子標的薬、細胞毒性薬、ホルモン薬、その他
  • 経口ペプチド薬のグローバル市場展望 2023年-2029年：リナクロチド、インスリン、プレカナチド、シクロスポリン、オクトレオチド
  • 胃酸分泌抑薬のグローバル市場展望 2023年-2029年：H2受容体拮抗薬、胃プロトンポンプ阻害薬、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23JU5389 )"新型薬物再構成システムのグローバル市場展望 2023年-2029年：瓶詰め、袋詰め" (英文：Novel Drug Reconstitution System Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。